Team

TEAM

PROFESSOR MINNA NYSTRÖM (PREV. NYSTRÖM­-LAHTI), PHD

FOUNDER AND CHAIRMAN

Professor Nyström is the leading inventor of DiagMMR® with more than 20 years of experience in the field of Lynch syndrome research and has had an active role in both the identification of the LS related genes and mutations as well as the bettering of LS recognition through over 50 scientific publications in the field. Prof. Nyström is an active member of the International Society for Gastrointestinal Hereditary Tumours, InSiGHT.

NIKLAS LAHTI

CHIEF FINANCIAL OFFICER

Mr. Lahti is responsible for operational and financial management, investor relations, and shareholder management. He has gained experience in investment banking and other industries before joining LS CancerDiag Ltd.

PHILIPPE ARNEZ, MSC

CHIEF BUSINESS OFFICER

Mr. Arnez brings a wealth of experience from corporate roles in major blue-chip companies on an international level in Europe and the Americas, with responsibilities for strategy development, change management, procurement and logistics. He is responsible for commercial partnerships, international expansion, marketing & communications, strategic planning.

DR. MINTTU KANSIKAS, PHD

CHIEF SCIENTIFIC OFFICER

Dr. Kansikas has worked on Lynch syndrome research in Prof. Nyström ́s lab for over 10 years and is a co-inventor of DiagMMR®. Her doctoral thesis, “Recognizing Lynch syndrome by DNA mismatch repair deficiency” focused on pathogenicity assessment and interpretation of LS associated mutations and functional detection of reduced mismatch repair.

DR. JUKKA KANTELINEN, PHD

LABORATORY DIRECTOR

Dr. Kantelinen has worked on DNA mismatch repair research in Prof. Nyström ́s lab for over 12 years. His doctoral thesis, “Functional characterization of MutS homologue mismatch repair proteins and their variants” focused on functional characterization of LS mutations and the key molecular components of the MMR mechanism.

DR. LAURA VÄHÄTALO, PHD

PRODUCTION MANAGER

Dr. Vähätalo is responsible for the laboratory production of the DiagMMR® assay, as well as the interpretation and management of the results. In addition to the production management, she also specializes in the quantitative detection method. She has extensive experience in molecular biology techniques and biomedical research.

DR. JAANA PUTULA, PHD

QUALITY MANAGER

Dr. Putula has vast experience in cell culture and works to ensure the meticulous handling of patient samples from sampling to testing. In addition to coordinating the sample handling and running the cell culture processes, she assists with other processes of the DiagMMR® testing.

MARIANN KASELA, MSC

RESEARCHER

MSc Kasela works as a researcher in LS CancerDiag Ltd and specializes in the functional assessment of MMR proteins. She has broad experience in MMR research, cell culture and biotechnology.